AffaMed Therapeutics
Wei (Michelle) Zhang has a strong background in biometrics and statistical analysis. Wei (Michelle) is currently serving as the Vice President and Head of Biometrics at AffaMed Therapeutics since February 2021. Prior to that, they were the Senior Director and Head of US at PPC优生 from March 2020 to February 2021. Wei (Michelle) also has experience working at the FDA, where they served as a Supervisory Mathematical Statistician from September 2017 to March 2020, and as a Mathematical Statistician from December 2009 to August 2017.
Wei (Michelle) Zhang holds a Doctor of Philosophy (PhD) degree in Statistics from the University of Pittsburgh. Previously, they completed their Bachelor's degree at the University of Science and Technology of China. In addition, they obtained a certification for The Science and Business of Biotechnology from edX in 2021.
This person is not in any offices
AffaMed Therapeutics
AffaMed Therapeutics is a clinical stage therapeutic company focused on developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmic, neurological and psychiatric disorders for patients in Greater China and around the world. The leadership team of AffaMed Therapeutics has gained deep industry expertise and an extensive track record in high-quality discovery, clinical development, regulatory affairs, manufacturing, commercial operations, and business development at leading multi-national pharmaceutical companies in China and globally.